CYBR

Sale of 150 shares of CyberArk (Entire Position); Purchase of 200 shares of Pagaya; Purchase of 200 shares of Rubrik; Purchase of 250 shares of Samsara; Purchase of 200 shares of Dynatrace; Purchase of 200 shares of Braze; Purchase of 50 shares of Atlassian; Purchase of 20 shares of Monday We have made some changes…

To access this post, you must subscribe.

Read More

We made some changes in the high-growth portfolio We sold another 400 shares of Rubrik at 99.73. That brings our holding down to 1100 shares. It now has a weight of approximately 8.1% in the high growth portfolio. The sale netted $39,880. As is often the case, Rubrik shares are having a hard time crossing the…

To access this post, you must subscribe.

Read More

AS we had discussed in this week’s commentary, we believed that the recent appreciation of IT stocks had taken some of the positions in the portfolio to valuations that were a bit stressed. Today, that opinion was seconded by the analyst team at Raymond James with regards to Nutanix. That precipitated our sale of a…

To access this post, you must subscribe.

Read More

On Wednesday evening, the President took revenge on the former Director of what is called the Cybersecurity and Infrastructure Security Agency, Chris Krebs for not supporting the allegations regarding the integrity of the 2020 presidential elections. The order included allegations against Krebs for allegedly “blinding” the American public about the controversy over Hunter Biden’s laptop,…

To access this post, you must subscribe.

Read More

Ticker Target Invest Philosophy In the wake of the excruciating fall of high growth IT shares I have been asked frequently about the Ticker Target investment philosophy and how it works in these difficult times. Obviously in looking at a drawdown of 34% in just over 6 weeks provides plenty of motivation for introspection and…

To access this post, you must subscribe.

Read More

As foreshadowed in the weekly commentary I have made some portfolio changes. The rationale for these changes was in the weekly commentary. That said, if anyone has questions about why I have made these changes, please let me know and I will answer rapidly. I do not like to make a lot of changes, but…

To access this post, you must subscribe.

Read More

I want to start by making an unusual comment. At Ticker Target, we make it a point to ensure that all of our subscribers receive content on a timely basis. If there is a problem, we want to know about it. To do so, however, we need some kind of payment confirmation information. We have…

To access this post, you must subscribe.

Read More

Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…

To access this post, you must subscribe.

Read More

Sale of 250 shares of Nutanix; Sale of 100 shares of Dynatrace; purchase of 150 shares of AppLovin; Purchase of 20 shares of CyberArk We made some changes to the high growth portfolio today. In general, my strategy is to hold positions long term. But sometimes, when I see tactical opportunities, I take them. I…

To access this post, you must subscribe.

Read More

Sale of 50 shares of Crowdstrike; Purchase of 80 shares of CyberArk Very reluctantly, we decided to sell 25% of our Crowdstrike position today. Our sale price was $348.49 and the sale raided about $17,415. Crowdstrike shares have risen by more than 18% in the last 3+ weeks. That kind of performance is far greater…

To access this post, you must subscribe.

Read More